↓ Skip to main content

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants

Overview of attention for article published in Frontiers in immunology, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
13 X users
patent
2 patents

Citations

dimensions_citation
126 Dimensions

Readers on

mendeley
162 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
Published in
Frontiers in immunology, January 2013
DOI 10.3389/fimmu.2013.00354
Pubmed ID
Authors

Seleeke Flingai, Matias Czerwonko, Jonathan Goodman, Sagar B. Kudchodkar, Kar Muthumani, David B. Weiner

Abstract

In recent years, DNA vaccines have undergone a number of technological advancements that have incited renewed interest and heightened promise in the field. Two such improvements are the use of genetically engineered cytokine adjuvants and plasmid delivery via in vivo electroporation (EP), the latter of which has been shown to increase antigen delivery by nearly 1000-fold compared to naked DNA plasmid delivery alone. Both strategies, either separately or in combination, have been shown to augment cellular and humoral immune responses in not only mice, but also in large animal models. These promising results, coupled with recent clinical trials that have shown enhanced immune responses in humans, highlight the bright prospects for DNA vaccines to address many human diseases.

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Sweden 1 <1%
Denmark 1 <1%
Unknown 160 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 26 16%
Student > Ph. D. Student 25 15%
Student > Master 22 14%
Student > Bachelor 17 10%
Student > Doctoral Student 8 5%
Other 21 13%
Unknown 43 27%
Readers by discipline Count As %
Agricultural and Biological Sciences 33 20%
Biochemistry, Genetics and Molecular Biology 28 17%
Immunology and Microbiology 19 12%
Medicine and Dentistry 11 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Other 18 11%
Unknown 46 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2023.
All research outputs
#1,518,858
of 25,373,627 outputs
Outputs from Frontiers in immunology
#1,343
of 31,513 outputs
Outputs of similar age
#13,236
of 288,986 outputs
Outputs of similar age from Frontiers in immunology
#13
of 503 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,513 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,986 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 503 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.